Caetano, G.C. et al. 2026. EVALUATION OF CYP2D6 POLYMORPHISM IN PATIENTS WITH BREAST CANCER AND TAMOXIFEN USERS OF TWO BREAST SERVICES OF BELO HORIZONTE. Mastology. 32, suppl.2 (Apr. 2026). DOI:https://doi.org/10.29289/259453942022V32S2031.